Schedule

The ACCP Updates in Therapeutics®: Pharmacotherapy Preparatory Review and Recertification Course will be held Saturday and Sunday, April 27-28, 2019.

Click below for the full meeting schedule.

Updates in Therapeutics® 2019 Preparatory
Review and Recertification Courses
April 27-28, 2019


Pharmacotherapy Preparatory Review and Recertification Course -- Cardiology I & II, and Critical Care

Saturday, April 27, 2019 from 1:30 PM to 5:30 PM CDT at Academic and Research Building: First and Second Floors, Auditorium

Available for 4.00 hours of CPE credit
Activity Number: 0217-0000-19-074-L01-P

Cardiology I
1:30 PM to 2:55 PM
Academic and Research Building: First and Second Floors, Auditorium

Speakers
Speaker: Shannon W. Finks, Pharm.D., FCCP, BCPS (AQ Cardiology), ASH-CHC
Professor of Clinical Pharmacy, University of Tennessee College of Pharmacy, Memphis, Tennessee
View Biography
Shannon W. Finks, Pharm.D., FCCP, BCPS (AQ Cardiology), ASH-CHC
Finks

Learning Objectives
1. Distinguish between the treatments for acute coronary syndrome: ST-segment elevation myocardial infarction and non–ST-segment elevation acute coronary syndrome.
2. Formulate evidence-based treatment strategies for patients with acute decompensated heart failure.
3. Devise a treatment plan for patients presenting with ventricular or life-threatening arrhythmias.
4. Differentiate between goals and treatment for hypertensive emergencies and hypertension without progressive organ damage
Cardiology II
2:55 PM to 4:20 PM
Academic and Research Building: First and Second Floors, Auditorium

Speakers
Speaker: Caitlin M. Gibson, PharmD, BCPS, BCCP
Assistant Professor of Pharmacotherapy, University of North Texas Health Science Center, Fort Worth, Texas
View Biography
Caitlin M. Gibson, PharmD, BCPS, BCCP
Gibson

Learning Objectives
1. Recommend patient-specific pharmacologic therapy for the management of chronic heart failure, with an emphasis on mortality-reducing agents and their target doses.
2. Develop an evidence-based pharmacologic regimen and monitoring plan for patients with atrial fibrillation.
3. Develop an optimal pharmacologic management plan for a patient with hypertension according to practice guidelines and clinical trial evidence.
4. Identify patients who are at risk of atherosclerotic cardiovascular disease (ASCVD) according to the pooled cohort equation to estimate the 10-year ASCVD risk and determine in whom statin therapy should be initiated and the appropriate intensity of statin therapy when applicable.
5. Determine the appropriate pharmacologic therapy for patients with stable coronary heart disease.
Networking Break
4:20 PM to 4:30 PM
Academic and Research Building: Second Floor Lobby
Browse the ACCP Bookstore, grab a beverage, and network with your fellow meeting attendees.
Critical Care
4:30 PM to 5:30 PM
Academic and Research Building: First and Second Floors, Auditorium

Speakers
Faculty: Corey J. Witenko, Pharm D., BCPS, BCCCP
Clinical Specialist - Surgical/ Trauma ICU, Director of PGY1 Pharmacy Residency Program, NewYork-Presbyterian Hospital/ Weill Cornell Medical Center, New York, New York
View Biography
Corey J. Witenko, Pharm D., BCPS, BCCCP
Witenko

Learning Objectives
1. Interpret hemodynamic parameters and acid-base status in critically ill patients.
2. Differentiate between presentation of and treatment strategies for hypovolemic, obstructive, cardiogenic,and distributive shock.
3. Discuss the appropriate use of fluids, vasopressors, antibiotics, and corticosteroids in patients with sepsis or septic shock.
4. Discuss strategies to optimize the safety and efficacy of therapeutic hypothermia for patients after cardiac arrest.
5. Recommend therapeutic options to minimize delirium and provide optimal analgesia, sedation, neuromuscular blockade, and nutritional support in critically ill patients.
6. Recommend therapeutic options to prevent stress ulcers, venous thromboembolism, hyperglycemia, and ventilator-associated pneumonia in critically ill patients.
7. Recommend treatment options for acute intracranial hemorrhage.